SABCS: Omission of SLNB Safe in Clinically T1

THURSDAY, Dec. 11, 2025 (HealthDay News) -- For patients with clinically T1-2 node-negative (cN0) breast cancer, the omission of sentinel lymph node biopsy (SLN

See Full Page

Interests (0)

Settings

SABCS: Omission of SLNB Safe in Clinically T1

The Senate voted down dueling health proposals. Here's what's at stake for Americans

Hundreds quarantined as measles spreads

Doughy Chocolate Chip Cookie packages pulled over salmonella concerns

Doctors deliver baby while removing 22-pound tumor from mother: 'Medical miracle'

Alarm as Trump admits to 3 cognitive tests monitored by room of doctors in late

Man Has Stroke Due to Energy Drinks: Are Any Energy Drinks Healthy?

Botulism outbreak sickens more than 50 babies and expands to all ByHeart products

How a rare drug made from scientists' blood saves babies from botulism

Bill of the Month: Not serious enough to turn on the siren, toddler’s 39-mile ambulance ride still cost over $9,000 – Baltimore Sun

Former Republican official says Trump's 'monumental ego' responsible for GOP's downfall

Radiological Society of North America, Nov. 30

SABCS: Breast MRI Does Not Increase Local Regional Control in Some Early

Planned Early-Term Birth Cuts Preeclampsia Incidence in High

Gorilla Dancing in a Forest Wins Comedy Wildlife Photo Awards 2025

Woman Killed in Freak Accident After Pole Came Crashing Down on Car

How Social Security beneficiaries' tax bills may change this year

Trump admin moves to end major student loan forgiveness plan: 'We won't tolerate it'

US seizes tanker off coast of Venezuela, Trump says

Here are the five big takeaways from Wednesday's Fed rate decision

USPS Announces Holiday Delivery Dates

1 dead, 1 injured in shooting at Kentucky State University, suspect in custody: Police

Teen football players arrested after alleged $2K Dick's Sporting Goods theft

Judge orders immediate release of Kilmar Abrego Garcia from immigration detention